Skip to main content

Table 4 Univariate and multivariate Cox regression analysis of second 3 point decrease of QMGS

From: Factors affecting improvement of neurologic status evaluated by Quantitative Myasthenia Gravis Score for patients with thymomatous myasthenia gravis after extended thymectomy

Parameters

Univariate

Multivariate

HR (95% CI)

P

HR (95% CI)

P

Sex

 Male

Ref.

  

 Female

1.11 (0.87 to 1.41)

0.398

  

Age, years

 < 42

Ref.

Ref.

 ≥ 42

0.52 (0.40 to 0.66)

 < 0.001

0.53 (0.41 to 0.68)

 < 0.001

Disease course, months

 < 8

Ref.

  

 ≥ 8

0.85 (0.67 to 1.07)

0.164

  

Preoperative steroids

 No

ref

  

 Yes

0.94 (0.74 to 1.20)

0.622

  

MGFA class

 I + IIA

Ref.

Ref.

 IIB–V

0.74 (0.57 to 0.96)

0.025

0.79 (0.61 to 1.03)

0.087

Surgical approach

 Sternotomy

Ref.

  

 VATS

1.12 (0.75 to 1.67)

0.577

  

Masaoka-Koga stage

 I

Ref.

Ref.

 IIa–IIIa

0.51 (0.32 to 0.80)

0.004

0.53 (0.33 to 0.84)

0.007

WHO pathologic type

 A + AB

Ref.

  

 B1–B3

1.23 (0.87 to 1.74)

0.237

  

Tumor size

 ≤ 5 cm

Ref.

Ref.

 > 5 cm

0.67 (0.45 to 0.98)

0.042

0.92 (0.61 to 1.39)

0.705

Complete resection

 No

Ref.

Ref.

 Yes

22.08 (2.03 to 240.48)

0.011

Failed estimationa

  1. aFailed estimation was due to insufficient number of cases
  2. CI, confidence interval; HR, hazard ratio; MGFA, Myasthenia Gravis Foundation of America; QMGS, Quantitative Myasthenia Gravis Score; VATS, video-assisted thoracoscopic surgery;WHO, World Health Organization